Hamartoma pathophysiology

Hamartoma Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Hamartoma from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
Staging
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
CT
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Hamartoma pathophysiology On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Hamartoma pathophysiology All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Hamartoma pathophysiology
CDC on Hamartoma pathophysiology
Hamartoma pathophysiology in the news
Blogs on Hamartoma pathophysiology
Directions to Hospitals Treating Hamartoma
Risk calculators and risk factors for Hamartoma pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Maria Fernanda Villarreal, M.D. [2]

Overview

Hamartomas arise from connective tissue and are generally formed of cartilage, fat, and connective tissue cells, although they may include many other types of cells. They can be located in lung (most common), heart, hypothalamus, kidneys, or spleen. There are many genetic syndromes that cause multiple hamartomas, such as; Peutz-Jeghers syndrome, PTEN hamartoma tumour syndrome andCowden’s syndrome . Genes involved in the pathogenesis of harmatomatous syndromes include BMPR1A, SMAD4, PTEN and STK11.

Pathogenesis

Hamartomas result from an abnormal formation of normal tissue, although the underlying reasons for the abnormality are not fully understood. They grow along with, and at the same rate as, the organ from whose tissue they are made, and, unlike cancerous tumors, only rarely invade or compress surrounding structures significantly.

Lung

The most common hamartomas occur in the lungs. About 5-8% of all solitary lung tumors, about 75% of all benign lung tumors are hamartomas. They almost always arise from connective tissue and are generally formed of cartilage, fat, and connective tissue cells, although they may include many other types of cells. The great majority of them form in the connective tissue on the outside of the lungs, although about 10% form deep in the linings of the bronchii. They can be worrisome, especially if situated deep in the lung, as it is important and sometimes difficult to distinguish them from malignancies. An x-ray will often not provide definitive diagnosis, and even a CT scan may be insufficient if the hamartoma atypically lacks cartilage and fat cells. Lung hamartomas are more common in men than in women and may present additional difficulties in smokers.

Some lung hamartomas can compress surrounding lung tissue to a degree, but this is generally not debilitative or even noticed by the patient, especially for the more common peripheral growths. They are treated, if at all, by surgical resection, with an excellent prognosis: generally, the only real danger is the inherent possibility of surgical complications.

Heart

Cardiac rhabdomyomas are hamartomas comprised of altered cardiac myocytes that contain large vacuoles and glycogen. They are the second most common tumor of the heart in children and infants (after fibromas). There is a strong association between cardiac rhabdomyomas and tuberous sclerosis (characterized by hamartomas of the central nervous system, kidneys and skin, as well as pancreatic cysts; 25-50% of patients with cardiac rhabdomyomas will have tuberous sclerosis, and up to 100% of patients with tuberous sclerosis will have cardiac masses by echocardiography. Symptoms depend on the size of the tumor, its location relative to the conduction system, and whether it obstructs blood flow. Symptoms are usually from congestive heart failure (in utero heart failure may occur). If patients survive infancy, their tumors may regress spontaneously; resection in symptomatic patients has good results.

Hypothalamus

One of the most troublesome hamartomas occurs on the hypothalamus. Unlike most such growths, a hypothalamic hamartoma is symptomatic; it most often causes gelastic seizures, and can cause visual problems, other seizures, rage disorders associated with hypothalamic diseases, and early onset of puberty. The symptoms typically begin in early infancy and are progressive, often into general cognitive and/or functional disability. Moreover, resection is usually difficult, as the growths are generally adjacent to, or even intertwined with, the optic nerve; however, the symptoms are resistant to medical control. Surgical techniques are improving and can result in immense improvement of prognosis.

Kidneys, spleen, and other vascular organs

One general danger of hamartoma is that they may impinge into blood vessels, resulting in a risk of serious bleeding. Because hamartoma typically lacks elastic tissue, it may lead to the formation of aneurysms and thus possible hemorrhage. Where a hamartoma impinges into a major blood vessel, such as the renal artery, hemorrhage must be considered life-threatening.

Hamartoma of the kidney is also called angiomyolipoma and can be associated with tuberous sclerosis. It is one of the more frequently seen hamartomas. The condition is more prevalent in women than men, and generally occurs in the right kidney. Hamartomas of the spleen are uncommon, but can be dangerous. About 50% of such cases manifest abdominal pain] and they are often associated with hematologic abnormalities and spontaneous rupture.

Genetics

Genes involved in the pathogenesis of harmatomatous syndromes include BMPR1A, SMAD4, PTEN and STK11.

Associated Conditions

Many hereditary syndromes are associated with hamartomatous formation. The familial inheritance diseases include; juvenile polyposis syndrome, Peutz-Jeghers syndrome, hereditary mixed polyposis syndrome (HMPS) and PTEN hamartoma tumour syndrome, Cowden’s syndrome, Bannayan-Riley-Ruvalcaba syndrome.

Cowden syndrome

Cowden syndrome is a serious genetic disorder characterized by multiple hamartomas. Usually skin hamartomas exist, and commonly (about 66% of cases) hamartoma of the thyroid gland exists. Additional growths can form in many parts of the body, especially in mucosa, the GI tract, bones, CNS, the eyes, and the genourinary tract. The hamartomas themselves may cause symptoms or even death, but morbidity is more often associated with increased occurrence of malignancies, usually in the breast or thyroid.

Gross Pathology

On gross pathology, a hallmark feature of hamartoma is a well-circumscribed mass that may show a variegated yellow and white appearance, which corresponds respectively to fat and cartilage.

Microscopic Pathology

On microscopic pathology, hamartomas have benign tumors features, such as; disorganized (non-neoplastic) growth, tissue of the region within it is found and no invasion to surrounding tissue or structures.

Common findings include:

Cartilage

• Single cells in lacunae surrounded by abundant matrix
• Paucicellular vis-a-vis malignant lesions

Fat (adipocytes)

• Respiratory epithelium (columnar epithelium with cilia) - lung hamartoma

Gallery

• 

  Low magnification micrograph of a pulmonary hamartoma. H&E stain.

• 

  Pulmonary hamartoma: The surrounding lung falls away from the well-circumscribed mass, a typical feature of these lesions. The hamartoma shows a variegated yellow and white appearance, which corresponds respectively to fat and cartilage.

• 

  Gross pathology of pulmonary hamartoma.

• 

  Epithelial lined clefts within myxoid fibrous connective tissue.

References

Template:WikiDoc Sources